title: Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment.
authors.affiliation: University of Oslo and Centre for Preventive Medicine, Ullevål University Hospital, Oslo, Norway. t.r.pedersen@medisin.uio.no
authors.forename: Terje R
authors.initials: TR
authors.lastname: Pedersen
authors.affiliation: Institute for Clinical Chemistry A and Laboratory Medicine, University of Munster, Germany.
authors.forename: Gerd
authors.initials: G
authors.lastname: Assmann
authors.affiliation: University Hospital Jean Minjoz, Besançon, France
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Bassand
authors.affiliation: Dyslipidaemia & Atherosclerosis Research Unit, National Institute for Health & Medical Research (INSERM), Unité 551, Hôpital de la Pitié, Paris, France
authors.forename: M John
authors.initials: MJ
authors.lastname: Chapman
authors.affiliation: Department of Cardiology, West-German Heart Center, University
  Duisburg-Essen, Germany.
authors.forename: Raimund
authors.initials: R
authors.lastname: Erbel
authors.affiliation: Department of Pharmacological Sciences, University of Milan, Italy.
authors.forename: Cesare
authors.initials: C
authors.lastname: Sirtori